Theravance Biopharma Inc. (TBPH)
NASDAQ · Healthcare
Theravance Biopharma Inc. Net Income 2012–2025
Theravance Biopharma Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Theravance Biopharma Inc. net income for the quarter ending March 31, 2026 was -4.9 M, a 63.67% decrease year-over-year.
- Theravance Biopharma Inc. net income for the twelve months ending March 31, 2026 was 39.9 M, a 180.13% decrease year-over-year.
- Theravance Biopharma Inc. annual net income for 2025 was 105.9 M, a 287.70% decrease from 2024.
- Theravance Biopharma Inc. annual net income for 2024 was -56.4 M, a 2.22% increase from 2023.
- Theravance Biopharma Inc. annual net income for 2023 was -55.2 M, a 106.33% decrease from 2022.
- Theravance Biopharma Inc. annual net income for 2022 was 872.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Theravance Biopharma Inc. Net Income — FAQ
Theravance Biopharma Inc. (TBPH) net income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Theravance Biopharma Inc.'s net income?
Theravance Biopharma Inc. (TBPH) reported net income of $106M for fiscal 2025.
Where can I see TBPH's net income history?
The chart and table above show Theravance Biopharma Inc.'s net income by year and by quarter, including the growth rate.